Promising diabetes delay study halted due to lack of participants
NCT ID NCT04291703
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tested a low dose of a drug called ATG to see if it could delay or prevent type 1 diabetes in people at high risk. Only 2 people enrolled, so the study was stopped early. The goal was to measure how long it took for participants to develop full diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barbara Davis Center at University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
-
Benaroya Research Institute
Seattle, Washington, 98101, United States
-
Children's Hospital of Iowa
Iowa City, Iowa, 52242, United States
-
Children's Hospital of Orange County
Orange, California, 92868, United States
-
Columbia University-Naomi Berrie Diabetes Center
New York, New York, 10032, United States
-
Emory Children's Center
Atlanta, Georgia, 30322, United States
-
Indiana University - Riley Hospital for Children
Indianapolis, Indiana, 46202, United States
-
Prisma Health
Greenville, South Carolina, 29615, United States
-
Queensland Children's Hospital
South Brisbane, Queensland, 4101, Australia
-
Stanford University
Stanford, California, 94305, United States
-
The Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
-
University of California - San Francisco
San Francisco, California, 94143, United States
-
University of Florida
Gainesville, Florida, 32610, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States
-
University of South Florida Diabetes Center
Tampa, Florida, 33612, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
-
University of Utah
Salt Lake City, Utah, 84132, United States
-
Vanderbilt Eskind Diabetes Center
Nashville, Tennessee, 37232, United States
-
Walter and Eliza Hall Institute of Medical Research
Melbourne, Victoria, 3050, Australia
-
Yale University School of Medicine
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.